Pierre-Yves Berclaz

EVP, Chief Medical Officer and Chief Science Officer at Ferring Pharmaceutical

United States

About

I am a Pediatric Pulmonologist and Molecular Biologist with extensive pharmaceutical senior leadership experience. Both in the US and in Japan, I have started-up organizations and capabilities, built and transformed them into high-performing cross-functional teams that are passionate about patient health. I particularly enjoy creating diverse teams, developing talent and innovating. I am recognized for being a dedicated, ethical leader, an agent of change and working with a patients’ centric mindset. I have managed large teams and portfolios of clinical and health outcomes studies in multiple therapeutic areas including Immunology (Rheumatology, Dermatology, Gastroenterology), Diabetes, Oncology, Endocrinology, Neurology (Alzheimer Dementia, Migraine, Pain and Multiple Sclerosis), Cardiology, Psychiatry, Men’s Health/Urology, Diagnostic and Molecular Imaging. My experience covers the entire value chain, in Development and Medical Affairs, from phase 1 to LOE. Earning the healthcare, access and patient communities’ trust with balanced, timely and clinically relevant information has been key to the successful introduction and sustained performance of novel products or indications in all of these therapeutic areas. Proven Abilities and Expertise in: *Global Organizational Leadership *Global Product Life-Cycle Strategic & Tactical Planning & Execution *Global Clinical, Health Outcomes & Real-World Evidence Research Design & Operations *External Reputation & Influence *Global Pharmaceutical Regulations & Compliance *Talent Management & Development *Medical Digital capabilities Special skills: * Immunology, Pulmonary Medicine, Pediatrics, Molecular and Developmental Biology * Medical Digital capabilities including Artificial Intelligence * Public Speaking experience in both English and French Industry experience: Bio-Pharmaceutical and Healthcare service sectors

Experience

  • Ferring Pharmaceuticals (On-site)
    • Executive Vice President, Chief Medical Officer and Chief Science Officer
      Mar 2024 - Present · 2 yrs 5 mos

    • Executive Vice President and Chief Medical Officer
      Jan 2023 - Mar 2024 · 1 yr 3 mos

  • Senior Vice President, Head Global Medical Affairs Neurology and Immunology at EMD Serono, Inc.
    Nov 2019 - Sep 2022 · 2 yrs 11 mos

  • Eli Lilly and Company (14 yrs 11 mos)
    • Senior Medical Director/Operating Officer Medical Science
      Aug 2013 - Nov 2019 · 6 yrs 4 mos

      Manage the Medical Science group responsible for R&D, Medical Affairs, Health Outcome across several therapeutic areas (CNS, Oncology, Diabetes, Osteoporosis, Autoimmune, CV, Urology) in Japan.

    • Chief Medical Officer
      Aug 2013 - Nov 2019 · 6 yrs 4 mos

    • Global Team Leader/Senior Medical Director
      2005 - Nov 2019 · 14 yrs 11 mos

      Immunomodulation. Autoimmunity. Inflammation. Cystic Fibrosis.